Detailed answers about NEUROHEALTH & SYSTEM ADVISORY LTD, including incorporation, status, business activity, and accounts information.
When was NEUROHEALTH & SYSTEM ADVISORY LTD founded?
NEUROHEALTH & SYSTEM ADVISORY LTD was officially incorporated on 8 April 2026 and is registered under company number 17142241. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NEUROHEALTH & SYSTEM ADVISORY LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NEUROHEALTH & SYSTEM ADVISORY LTD?
NEUROHEALTH & SYSTEM ADVISORY LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NEUROHEALTH & SYSTEM ADVISORY LTD do?
NEUROHEALTH & SYSTEM ADVISORY LTD operates in the following sectors: 70229 - Management consultancy activities other than financial management, 84120 - Regulation of health care, education, cultural and other social services, not incl. social security, 85590 - Other education n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is NEUROHEALTH & SYSTEM ADVISORY LTD's registered address?
The registered office address of NEUROHEALTH & SYSTEM ADVISORY LTD is 9 Priory Way, Newcastle Upon Tyne, United Kingdom, NE5 4PN. This is the official address filed with Companies House for legal and statutory correspondence.
Is NEUROHEALTH & SYSTEM ADVISORY LTD financially stable?
Financial accounts for NEUROHEALTH & SYSTEM ADVISORY LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.